J.-J. Kim et al. / Tetrahedron Letters 45 (2004) 8781–8784
Table 4. N-Arylation of 4,5-dichloropyridazin-3(2H)-one (1a) using
8783
Supplementary data
lead tetraacetate (1.2equiv)/ZnCl2 (1equiv) in refluxing substituted
benzene
Supplementary data associated with this article can
Entry Substituted benzene Time (h) Products Yield (%)a
1
2
3
4
5
6
7
Toluene
m-Xylene
20
25
11
40
39
20
10
2g (32)
2h (65)
2i (27)
2j (30)
2k (24)
2l (38)
—
3g (22)
—
Nitrobenzene
Chlorobenzene
Bromobenzene
Methoxybenzene
N-Methyl-N-
phenylformamide
3i (34)
3j (46)
3k (28)
3l (29)
3m (57)
References and notes
1. Coates, W. J. In Pyridazines and Their Benzo Derivatives in
Comprehensive Heterocyclic Chemistry II; Katritzky, A.
R., Rees, C. W., Scrivan, E. F. V., Eds.; Pergamon: New
York, 1996; Vol. 6, pp 1–91.
a Isolated yields.
2. Curran, W. V.; Ross, A. J. Med. Chem. 1974, 17, 273.
3. Maseri, A.; Pesola, A.; LꢀAbbete, A.; Contini, C.; Magini,
G. J. Int. Med. Res. 1976, 4, 402.
and zinc chloride (1.82mmol). The mixture was stirred
for 10min and than refluxed for 20–48h untilpyrid-
azine-3(2H)-one disappeared. After filtering the reaction
mixture, the solvent was evaporated under reduced pres-
sure, and the resulting residue was applied to the top of
an open-bed silica gel column (3 · 10cm), and the col-
umn was eluted with CH2Cl2/n-hexane = 2:1 (v/v). The
fractions containing product were combined and evapo-
rated under reduced pressure to afford the correspond-
ing N-arylpyridazin-3(2 H)-one 2 in good yields.
4. Kamiya, S.; Anzai, M.; Nakashima, T.; Sueyoshi, S.;
Tanno, M. Chem. Pharm. Bull. 1977, 25, 504.
5. Rapos, P.; Winternitz, P. French Demande 1,461,373, 9
December 1966; Chem. Abstr. 1967, 67, 90824g.
6. Rapos, P.; Winternitz, P. Czech Patent 120,858, 15
December 1966; Chem. Abstr. 1968, 68, 78303z.
7. Sandoz Ltd., by Ebner, C.; Schuler, M. Swiss Patent
482,684, 30 January 1970; Chem. Abstr. 1970, 72,
121567k.
8. Yamasaki, T.; Kawaminami, E.; Uchimura, F.; Okomota,
Y.; Okawara, T.; Furukawa, M. J. Heterocycl. Chem.
1992, 29, 825.
9. Kappe, T. J. Heterocycl. Chem. 1998, 35, 1111.
10. Sotelo, E.; Fraiz, N.; Yanez, M.; Laguna, R.; Cano, E.;
Brea, J.; Ravina, E. Bioorg. Med. Chem. Lett. 2002, 12,
1575.
4,5-Dichloro-2-phenylpyridazin-3(2H)-one (2a): White
solid; mp 161–162ꢁC; Rf (CH2Cl2) = 0.67; IR (KBr)
3272, 3050, 2922, 1652, 1544, 1408, 1296, 1084, 1072,
1
660cmÀ1; H NMR (CDCl3) d 7.91 (s, 1H), 7.59–7.56
(m, Aro–2H), 7.50–7.47 (m, Aro–2H), 7.44–7.42 (m,
Aro–1H); 13C NMR (CDCl3) d 125.18, 128.89, 128.95,
135.36, 136.11, 136.37, 140.90, 176.63. Anal. Calcd for
C10H6Cl2N2O: C, 49.82; H, 2.51; N, 11.62. Found: C,
49.75; H, 2.39; N, 11.59.
11. Sotelo, E.; Fraiz, N.; Yanez, M.; Terrades, V.; Laguna, R.;
Cano, E.; Ravina, E. Bioorg. Med. Chem. Lett. 2002, 10,
2873.
12. Dury, K. Angew. Chem., Intl. Ed. Engl. 1965, 4, 292.
13. Schober, B. D.; Megyeri, G.; Kappe, T. J. Heterocycl.
Chem. 1989, 26, 169.
14. Al-Omran, F.; Al-Awadl, N.; Yousef, O.; Elnagdi, M. H.
J. Heterocycl. Chem. 2000, 37, 167.
15. Patel, H. V.; Vyas, K. A.; Pandey, S. P.; Tavares, F.;
Fernandes, P. S. Synth. Commun. 1991, 21, 1935.
16. Abed, N. M.; Ibrahim, N. S.; Fahmy, S. M.; Elnagdi, M.
H. Org. Prep. Proc. Int. 1985, 17, 107.
17. Behbehani, H.; Abdel-Khalik, M. M.; Elnagdi, M. H. Org.
Prep. Proc. Int. 1999, 31, 551.
18. Hegde, S. G.; Jones, C. R. J. Heterocycl. Chem. 1993, 30,
1501.
4-Chloro-5-methoxy-2-phenylpyridazin-3(2H)-one (2b):
White solid; mp 153–154 ꢁC; Rf (CH2Cl2) = 0.28; IR
(KBr) 3070, 2970, 2880, 1645, 1610, 1480, 1460, 1400,
1300, 1240, 1150, 1100, 950, 830, 760, 680cmÀ1 1H
;
NMR (CDCl3) d 7.95 (s, 1H), 7.58–7.54 (m, Aro–2H),
7.50–7.39 (m, Aro–3H), 4.09 (s, 3H); 13C NMR (CDCl3)
d 57.82, 117.29, 125.36, 127.13, 128.51, 128.80, 141.29,
154.70, 158.30. Anal. Calcd for C11H9ClN2O2: C, 55.83;
H, 3.83; N, 11.84. Found: C, 55.78; H, 3.92; N, 11.99.
19. Erian, A. W.; Issac, Y. A. E.; Sherif, S. M.; Mahmoud, F.
F. J. Chem. Soc., Perkin. Trans. 1 2000, 3686.
20. Tisler, M.; Stanovnik, B. In Pyridazines in Advances in
Heterocyclic Chemistry; Katritzky, A. R., Boulton, A. J.,
Eds.; Academic: New York, 1968; Vol. 9, pp 211–
320.
21. Tisler, M.; Stanovnik, B. In Recent Advances in Pyridazine
Chemistry in Advances in Heterocyclic Chemistry; Kat-
ritzky, A. R., Rees, C. W., Scrivan, E. F. V., Eds.;
Academic: New York, 1979; Vol. 24, pp 363–456.
22. Kunz, K.; Scholz, U.; Ganzer, D. Synlett 2003, 2428.
23. (a) Khan, M. A.; Polya, J. B. J. Chem. Soc. (C) 1970, 85;
(b) Klapars, A.; Antilla, J. C.; Hung, X.; Buchwals, S. L.
J. Am. Chem. Soc. 2001, 123, 7727.
24. Lam, P. Y. S.; Clark, C. G.; Saubern, S.; Adams, J.;
Winters, M. P.; Chan, D. M. T.; Combs, A. Tetrahedron
Lett. 1998, 39, 2941.
25. Lam, P. Y. S.; Deudon, S.; Averill, K. M.; Li, R.; He,
M. Y.; Deshong, P.; Clark, C. G. J. Am. Chem. Soc. 2000,
122, 7600.
5-Azido-4-chloro-2-phenylpyridazin-3(2H)-one
(2c):
White solid; mp. 99–100ꢁC; Rf (CH2Cl2) = 0.38; IR
(KBr) 3070, 2980, 2950, 2890, 2150, 1660, 1600, 1500,
1
1380, 1330, 1310, 1150, 840, 780, 700 cmÀ1; H NMR
(CDCl3) d 7.76 (s, 1H), 7.58–7.55 (m, Aro–2H), 7.51–
7.41 (m, Aro–3H); 13C NMR (CDCl3) d 123.35,
125.17, 128.70, 128.86, 130.27, 139.11, 140.96, 156.81.
Anal. Calcd for C10H6ClN5O: C, 48.50; H, 2.44; N,
28.28. Found: C, 48.54; H, 2.45; N, 28.32.
Acknowledgements
This work was supported by a grant from the Korea Sci-
ence and Engineering Foundation (KOSEF) to the
EnvironmentalBiotechnool gy NationalCore Research
Center (grant #: R15-2003-012-02001-0).